The pharmaceutical firm Pfizer is the only producer of penicillin G benzathine, the one medication that safely treats syphilis in pregnant folks. Credit score: Pixabay/CC0 Public Area
Pfizer was poised to seal a takeover of Metsera on Saturday after its improved provide gained over the biotechnology startup’s board and Danish challenger Novo Nordisk known as a halt to a back-and-forth bidding conflict.
Metsera, a US agency specializing in weight problems remedies, has been the topic of escalating presents from US pharma large Pfizer and Novo Nordisk, which makes the weight-loss drug Wegovy and the antidiabetic remedy Ozempic.
In a press launch Friday, Metsera stated Pfizer had made an improved provide to amass it for as much as $86.25 per share, in a deal value round $10 billion.
Metsera stated its board “unanimously recommends that… stockholders approve the adoption of the amended Pfizer merger agreement and approve the merger.”
It added that it anticipated to shut the deal “promptly” after a shareholder assembly on November 13.
Pfizer’s newest provide would double its valuation in comparison with an preliminary deal the businesses struck in September, which triggered a counteroffer from Novo Nordisk that spiraled right into a worth conflict.
The Danish agency stated Saturday that it “does not intend to make an increased offer to acquire Metsera.”
The corporate “will continue to assess opportunities for business development and acquisitions that… further its strategic objectives,” it stated.
The Novo Nordisk sale had drawn scrutiny over potential antitrust implications.
Metsera stated the US Federal Commerce Fee had known as it to debate “potential risks from proceeding with the proposed Novo Nordisk structure under US antitrust laws.”
The decision strengthened the board’s conclusion that the Novo Nordisk deal “presents unacceptably high legal and regulatory risks… compared to the proposed merger with Pfizer.”
Novo Nordisk stated it believed that its potential deal was “compliant with antitrust laws.”
The World Well being Group says multiple billion folks worldwide lived with weight problems, and greater than 800 million lived with diabetes as of 2022.
© 2025 AFP
Quotation:
Pfizer poised to purchase Metsera in $10 bn deal after bidding conflict (2025, November 8)
retrieved 8 November 2025
from https://medicalxpress.com/information/2025-11-pfizer-poised-buy-metsera-bn.html
This doc is topic to copyright. Aside from any honest dealing for the aim of personal research or analysis, no
half could also be reproduced with out the written permission. The content material is offered for info functions solely.
